US and European bases of operation will 'give us runway to continue doing what we’ve been doing', says PE chief Jim Pittman, including 'growing our book of directs'.
The UK’s £34.6bn medical research endowment warns of difficult period ahead for private equity, marked by subdued distributions and longer fundraising cycles.
GP and LPs, including the California Public Employees’ Retirement System and Alaska Permanent Fund, have contended with staff turnover at a time of congested fundraising and market uncertainty.
Several of PE's largest firms have made real strides in expanding access this year, though questions remain over whether individual investors are being adequately educated.
In this second episode of our miniseries Private Markets and the End of Cheap Money, we talk to LPs about allocation shifts, impacts on fundraising and what investors are looking for out of their GPs as rates rise.
Only 27% of LPs plan to increase their allocations to private equity over the next 12 months, down from 42% six months ago, according to Coller Capital’s latest barometer.